STAA

STAAR SURGICAL CO

Nasdaq · Ophthalmic Goods · Inc. DE · CIK 0000718937

$29.96 -0.10% $1.5B

High Impact Filing (8/10)3 New Institutional Positions

Vol

Market Cap$1.5B

Cap SizeSmall Cap

Analyst ConsensusHold (41%)

Inst. Holders8 funds

Inst. Value$137.7M

Inst. Activity3 buys / 1 sells

Insider Activity3B / 0S

Insider Net $$12.3M

SEC Reports2

Exchange Nasdaq·Sector Ophthalmic Goods·Inc. DE·CIK 0000718937·Prev Close $29.99

Recent Activity

May 15, 2026 Insider

Foust Warren sold 14,662 shares

Interim Co-CEO and Pres. & COO @ $0.00 ($0.00)

May 15, 2026 Insider

Foust Warren sold 7,460 shares

Interim Co-CEO and Pres. & COO @ $32.07 ($239.2K)

May 15, 2026 Insider

Foust Warren sold 14,662 shares

Interim Co-CEO and Pres. & COO @ $0.00 ($0.00)

May 13, 2026 SEC

STAAR Surgical reported a transformative Q1 2026 with record net sales of $93.5M (+119.6% YoY), driven by a recovery in

8-K — Impact 8/10

Apr 8, 2026 SEC

STAAR Surgical reported preliminary Q1 2026 net sales exceeding $90 million, more than double the $42.6 million from Q1

8-K — Impact 7/10

Inst.

MORGAN STANLEY — ADD

928,914 shares ($21.4M)

Inst.

WELLS FARGO & COMPANY/MN — ADD

56,653 shares ($1.3M)

May 13, 2026 earnings_calendar

STAA Q1 2026 Earnings Scheduled — 2026-05-13

Price Targets

$29.67 -0.7% upside Hold

Current $29.87 Low $23.00 Median $29.00 High $40.00 9 analysts

$23.00 $40.00

Analyst Ratings

Hold41% buy · 17 analysts

2Strong Buy

5Buy

10Hold

0Sell

0Strong Sell

Recent Analyst Actions

Date	Firm	Action	Rating
May 29, 2026	Wedbush	REITERATE	Outperform → Outperform
May 15, 2026	Wells Fargo	MAINTAIN	Equal-Weight → Equal-Weight
May 14, 2026	Canaccord Genuity	MAINTAIN	Buy → Buy
May 14, 2026	Piper Sandler	MAINTAIN	Neutral → Neutral
May 14, 2026	Stifel	MAINTAIN	Hold → Hold

Earnings Estimates

Period	EPS Est.	Range	Growth	#
Current Q	$0.23 ▲ +15.0%	$0.05 — $0.34	277% YoY	8
Next Q	$0.16 ▼ -9.9%	$0.07 — $0.29	-67% YoY	8
Current FY	$0.74 ▲ +33.1%	$0.39 — $1.18	542% YoY	8
Next FY	$0.99 ▲ +28.2%	$0.62 — $1.44	34% YoY	8

Latest Reports

BULLISH 8-K 8/10

STAAR Surgical reported a transformative Q1 2026 with record net sales of $93.5M (+119.6% YoY), driven by a recovery in

May 13, 2026

BULLISH 8-K 7/10

STAAR Surgical reported preliminary Q1 2026 net sales exceeding $90 million, more than double the $42.6 million from Q1

Apr 8, 2026

Top Institutional Holders

Fund	Value	Move
VANGUARD GROUP INC	$97.6M	—
MORGAN STANLEY	$21.4M	ADD
CHARLES SCHWAB INVESTMENT MANAGEMENT	$11.1M	NEW
TWO SIGMA INVESTMENTS, LP	$2.6M	TRIM
BANK OF AMERICA CORP	$2.3M	NEAR_EXIT

Recent Insider Trades

Date	Insider	Type	Value
May 15, 2026	Foust Warren	A	$0.00
May 15, 2026	Foust Warren	F	$239.2K
May 15, 2026	Foust Warren	M	$0.00
May 15, 2026	ANDREWS DEBORAH	A	$0.00
May 15, 2026	Michna Magda	A	$0.00

8 institutional holders with $137.7M total value (5,961,726 shares) as of 2025-Q4. Top holders: VANGUARD, MORGAN, CHARLES. Net buying activity: 3 institutions added/increased vs 1 reduced.

Top Institutional Holders — 2025-Q4

#	Fund	Shares	Value	% of Tracked	Last Move
1	VANGUARD GROUP INC	4,226,563	$97.6M	70.9%	—
2	MORGAN STANLEY	928,914	$21.4M	15.6%	ADD +87.1%
3	CHARLES SCHWAB INVESTMENT MANAGEMENT INC	480,604	$11.1M	8.1%	NEW
4	TWO SIGMA INVESTMENTS, LP	113,857	$2.6M	1.9%	TRIM -72.1%
5	BANK OF AMERICA CORP /DE/	100,765	$2.3M	1.7%	NEAR_EXIT -90.6%
6	WELLS FARGO & COMPANY/MN	56,653	$1.3M	1.0%	ADD +74.8%
7	RENAISSANCE TECHNOLOGIES LLC	37,800	$872.8K	0.6%	NEW
8	FMR LLC	16,570	$382.6K	0.3%	TRIM -73.1%

Recent Position Changes

Fund	Action	Prev Shares	Curr Shares	Change %	Value	Quarter
MORGAN STANLEY	ADD	496,591	928,914	+87.1%	$21.4M	2025-Q4
WELLS FARGO & COMPANY/MN	ADD	32,412	56,653	+74.8%	$1.3M	2025-Q4
RENAISSANCE TECHNOLOGIES LLC	NEW	—	37,800	—	$872.8K	2025-Q4
FMR LLC	TRIM	61,560	16,570	-73.1%	$382.6K	2025-Q4
MORGAN STANLEY	TRIM	1,312,303	496,591	-62.2%	$13.3M	2025-Q3
TWO SIGMA INVESTMENTS, LP	TRIM	407,381	113,857	-72.1%	$3.1M	2025-Q3
BANK OF AMERICA CORP /DE/	NEAR_EXIT	1,153,895	108,678	-90.6%	$2.9M	2025-Q3
FMR LLC	DOUBLED	15,268	61,560	+303.2%	$1.7M	2025-Q3
RENAISSANCE TECHNOLOGIES LLC	EXIT	31,900	0	-100.0%	$0.00	2025-Q3
MORGAN STANLEY	ADD	758,789	1,312,303	+72.9%	$22.0M	2025-Q2
TWO SIGMA INVESTMENTS, LP	DOUBLED	88,404	407,381	+360.8%	$6.8M	2025-Q2
RENAISSANCE TECHNOLOGIES LLC	TRIM	65,400	31,900	-51.2%	$535.3K	2025-Q2
FMR LLC	DOUBLED	3,789	15,268	+303.0%	$256.2K	2025-Q2
UBS Group AG	DOUBLED	72,152	236,838	+228.2%	$4.2M	2025-Q1
TWO SIGMA INVESTMENTS, LP	NEW	—	88,404	—	$1.6M	2025-Q1
RENAISSANCE TECHNOLOGIES LLC	TRIM	138,100	65,400	-52.6%	$1.2M	2025-Q1
FMR LLC	DOUBLED	1,802	3,789	+110.3%	$66.8K	2025-Q1
CITADEL ADVISORS LLC	TRIM	1,178,528	427,924	-63.7%	$10.4M	2024-Q4
RENAISSANCE TECHNOLOGIES LLC	TRIM	303,900	138,100	-54.6%	$3.4M	2024-Q4
UBS Group AG	DOUBLED	19,043	72,152	+278.9%	$1.8M	2024-Q4
WELLS FARGO & COMPANY/MN	ADD	20,509	26,081	+27.2%	$633.5K	2024-Q4
NORGES BANK	EXIT	272,445	0	-100.0%	$0.00	2024-Q4
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	NEW	—	426,122	—	$15.8M	2024-Q3

7 unique insiders with 3 transactions. Net insider value: $12.3M ($12.3M bought, $0.00 sold).

Insider Transactions

Date	Insider	Title	Type	Shares	Price	Value
May 15, 2026	Foust Warren	Interim Co-CEO and Pres. & COO	A	14,662	$0.00	$0.00
May 15, 2026	Foust Warren	Interim Co-CEO and Pres. & COO	F	7,460	$32.07	$239.2K
May 15, 2026	Foust Warren	Interim Co-CEO and Pres. & COO	M	14,662	$0.00	$0.00
May 15, 2026	ANDREWS DEBORAH J	Interim Co-CEO and CFO	A	10,466	$0.00	$0.00
May 15, 2026	Michna Magda	Chief Development Officer	A	10,997	$0.00	$0.00
May 15, 2026	ANDREWS DEBORAH J	Interim Co-CEO and CFO	F	3,755	$32.07	$120.4K
May 15, 2026	ANDREWS DEBORAH J	Interim Co-CEO and CFO	M	10,466	$0.00	$0.00
May 15, 2026	Michna Magda	Chief Development Officer	F	5,595	$32.07	$179.4K
May 15, 2026	Michna Magda	Chief Development Officer	M	10,997	$0.00	$0.00
May 8, 2026	Michna Magda	Chief Development Officer	F	1,680	$26.69	$44.8K
May 8, 2026	Foust Warren	Interim Co-CEO and Pres. & COO	F	3,448	$26.69	$92.0K
Mar 14, 2026	Michna Magda	Chief Development Officer	M	14,663	$0.00	$0.00
Mar 14, 2026	Foust Warren	Interim Co-CEO and Pres. & COO	M	19,550	$0.00	$0.00
Mar 14, 2026	Foust Warren	Interim Co-CEO and Pres. & COO	M	19,550	$0.00	$0.00
Mar 14, 2026	Michna Magda	Chief Development Officer	F	6,313	$18.84	$118.9K
Mar 14, 2026	Michna Magda	Chief Development Officer	M	14,663	$0.00	$0.00
Mar 13, 2026	ANDREWS DEBORAH J	Interim Co-CEO and CFO	A	39,809	$0.00	$0.00
Mar 13, 2026	BROADWOOD PARTNERS, L.P.	Director	BUY	316,017	$18.62	$5.9M
Mar 13, 2026	Foust Warren	Interim Co-CEO and Pres. & COO	A	45,117	$0.00	$0.00
Mar 13, 2026	Michna Magda	Chief Development Officer	A	33,838	$0.00	$0.00
Mar 12, 2026	Michna Magda	Chief Development Officer	F	2,216	$18.39	$40.8K
Mar 12, 2026	BROADWOOD PARTNERS, L.P.	Director	BUY	299,432	$18.12	$5.4M
Mar 12, 2026	Foust Warren	Interim Co-CEO and Pres. & COO	M	8,175	$0.00	$0.00
Mar 12, 2026	Foust Warren	Interim Co-CEO and Pres. & COO	M	8,175	$0.00	$0.00
Mar 12, 2026	Michna Magda	Chief Development Officer	M	6,178	$0.00	$0.00
Mar 12, 2026	Michna Magda	Chief Development Officer	M	6,178	$0.00	$0.00
Mar 11, 2026	BROADWOOD PARTNERS, L.P.	Director	BUY	54,764	$17.52	$959.6K
Mar 6, 2026	Wang Christopher Min Fang	Director	A	7,524	$0.00	$0.00
Mar 6, 2026	Bradsher Neal C	Director	A	7,524	$0.00	$0.00
Mar 6, 2026	LeBuhn Richard T.	Director	A	7,524	$0.00	$0.00
Feb 2, 2026	Foust Warren	Interim Co-CEO and Pres. & COO	A	20,787	$0.00	$0.00
Feb 2, 2026	ANDREWS DEBORAH J	Interim Co-CEO and CFO	A	20,787	$0.00	$0.00

2 SEC filing reports analyzed. Sentiment: 2 bullish, 0 bearish, 0 mixed, 0 neutral. Avg impact: 7.5/10.

BULLISH 8-K 8/10

STAAR Surgical reported a transformative Q1 2026 with record net sales of $93.5M (+119.6% YoY), driv

May 13, 2026

BULLISH 8-K 7/10

STAAR Surgical reported preliminary Q1 2026 net sales exceeding $90 million, more than double the $4

Apr 8, 2026

∅

No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.

Current analyst consensus: Hold (41% buy). Based on 17 analysts: 2 strong buy, 5 buy, 10 hold, 0 sell, 0 strong sell.

Analyst Price Targets

$29.67 mean target -0.7% upside Hold (2.45)

$23.00 Low $40.00 High

Metric	Value
Current Price	$29.87
Target Low	$23.00
Target Mean	$29.67
Target Median	$29.00
Target High	$40.00
# Analysts	9
Recommendation	Hold (2.45)

Earnings Estimates & Revisions

Period	EPS Avg	EPS Low	EPS High	EPS Growth	30d Rev.	Up/Down	Rev. Avg	Rev. Growth	Analysts
Current Q 2026-06-30	$0.23	$0.05	$0.34	277.2%	+15.0%	4↑ 0↓	$0.1B	103.5%	8
Next Q 2026-09-30	$0.16	$0.07	$0.29	-66.8%	-9.9%	3↑ 0↓	$0.1B	-14.2%	8
Current FY 2026-12-31	$0.74	$0.39	$1.18	542.3%	+33.1%	3↑ 1↓	$0.3B	39.6%	8
Next FY 2027-12-31	$0.99	$0.62	$1.44	34.1%	+28.2%	5↑ 0↓	$0.4B	7.6%	8

Current Quarter EPS Revision History

Timepoint	EPS Estimate	Change
Current	$0.226
7d ago	$0.197	+0.030
30d ago	$0.197	+0.030
60d ago	$0.223	+0.004
90d ago	$0.163	+0.063

7 analyst firms have rated this stock: 2 upgrades, 0 downgrades, 1 initiations.

Individual Analyst Actions

Date	Analyst Firm	Action	Previous Rating	New Rating
May 29, 2026	Wedbush	REITERATE	Outperform	Outperform
May 15, 2026	Wells Fargo	MAINTAIN	Equal-Weight	Equal-Weight
May 14, 2026	Canaccord Genuity	MAINTAIN	Buy	Buy
May 14, 2026	Piper Sandler	MAINTAIN	Neutral	Neutral
May 14, 2026	Stifel	MAINTAIN	Hold	Hold
May 14, 2026	Wedbush	UPGRADE	Neutral	Outperform
May 14, 2026	Mizuho	MAINTAIN	Neutral	Neutral
Apr 9, 2026	Wedbush	MAINTAIN	Neutral	Neutral
Apr 9, 2026	Canaccord Genuity	UPGRADE	Hold	Buy
Mar 5, 2026	Wells Fargo	MAINTAIN	Equal-Weight	Equal-Weight
Mar 4, 2026	Stifel	MAINTAIN	Hold	Hold
Feb 9, 2026	Stifel	MAINTAIN	Hold	Hold
Feb 3, 2026	Wedbush	INITIATE	—	Neutral
Jan 28, 2026	Jefferies	MAINTAIN	Buy	Buy
Jan 16, 2026	Canaccord Genuity	MAINTAIN	Hold	Hold

Monthly Consensus History

Period	Strong Buy	Buy	Hold	Sell	Strong Sell	Buy %
May 1, 2026	2	5	10	0	0	41%
Apr 1, 2026	2	4	11	0	0	35%
Mar 1, 2026	0	0	12	2	2	0%
Feb 1, 2026	0	0	11	2	2	0%
Jan 1, 2026	0	0	11	1	2	0%

Strong BuyBuyHoldSellStrong Sell

∅

No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.

∅

No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.

May 13, 2026

earnings_calendar

STAA Q1 2026 Earnings Scheduled — 2026-05-13

May 6, 2026

earnings_calendar

STAA Q1 2026 Earnings Scheduled — 2026-05-06

May 5, 2026

earnings_calendar

STAA Q1 2026 Earnings Scheduled — 2026-05-05

Apr 24, 2026

short_interest

FTD: STAA — 265,060 shares ($6.6M) failed to deliver

Settlement: 20260424, Price: $24.84, FTD Value: $6,584,090.4, STAAR SURGICAL CO

Apr 23, 2026

short_volume

Short Volume: STAA — 73.0% short (0.4M / 0.6M)

Short: 419,820 | Exempt: 0 | TRF Vol: 575,206 | Short Ratio: 73.0% | Off-exchange volume (dark pool + OTC)

Apr 13, 2026

short_volume

Short Volume: STAA — 56.8% short (0.4M / 0.7M)

Short: 379,699 | Exempt: 563 | TRF Vol: 668,620 | Short Ratio: 56.8% | Off-exchange volume (dark pool + OTC)

Apr 6, 2026

short_interest

FTD: STAA — 33,653 shares ($0.7M) failed to deliver

Settlement: 20260406, Price: $20.21, FTD Value: $680,127.13, STAAR SURGICAL CO

Apr 2, 2026

short_interest

FTD: STAA — 33,647 shares ($0.7M) failed to deliver

Settlement: 20260402, Price: $19.33, FTD Value: $650,396.51, STAAR SURGICAL CO

Apr 1, 2026

short_interest

FTD: STAA — 33,590 shares ($0.6M) failed to deliver

Settlement: 20260401, Price: $18.70, FTD Value: $628,133, STAAR SURGICAL CO

Mar 30, 2026

short_volume

Short Volume: STAA — 80.0% short (0.6M / 0.7M)

Short: 569,310 | Exempt: 0 | TRF Vol: 711,453 | Short Ratio: 80.0% | Off-exchange volume (dark pool + OTC)

Mar 20, 2026

short_interest

FTD: STAA — 189,162 shares ($3.3M) failed to deliver

Settlement: 20260320, Price: $17.47, FTD Value: $3,304,660.14, STAAR SURGICAL CO

Mar 3, 2026

earnings_calendar

STAA Q4 2025 Earnings After Market Close — 2026-03-03

Feb 25, 2026

earnings_calendar

STAA Q4 2025 Earnings After Market Close — 2026-02-25